165 related articles for article (PubMed ID: 16763020)
1. Metabolism of 3-nitrotyrosine induces apoptotic death in dopaminergic cells.
Blanchard-Fillion B; Prou D; Polydoro M; Spielberg D; Tsika E; Wang Z; Hazen SL; Koval M; Przedborski S; Ischiropoulos H
J Neurosci; 2006 Jun; 26(23):6124-30. PubMed ID: 16763020
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic Dysfunction in Mammalian Dopamine Neurons Induced by Simazine Neurotoxicity.
Li X; Yu J; Li J; Wu Y; Li B
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29137186
[TBL] [Abstract][Full Text] [Related]
3. Endogenous dopamine is involved in the herbicide paraquat-induced dopaminergic cell death.
Izumi Y; Ezumi M; Takada-Takatori Y; Akaike A; Kume T
Toxicol Sci; 2014 Jun; 139(2):466-78. PubMed ID: 24743698
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-free herpes simplex virus type 1 vector supports high-level, long-term biochemical and behavioral correction of a rat model of Parkinson's disease.
Sun M; Kong L; Wang X; Holmes C; Gao Q; Zhang GR; Pfeilschifter J; Goldstein DS; Geller AI
Hum Gene Ther; 2004 Dec; 15(12):1177-96. PubMed ID: 15684695
[TBL] [Abstract][Full Text] [Related]
5. Incorporation of 3-nitrotyrosine into the C-terminus of alpha-tubulin is reversible and not detrimental to dividing cells.
Bisig CG; Purro SA; Contín MA; Barra HS; Arce CA
Eur J Biochem; 2002 Oct; 269(20):5037-45. PubMed ID: 12383263
[TBL] [Abstract][Full Text] [Related]
6. Involvement of proinflammatory factors, apoptosis, caspase-3 activation and Ca2+ disturbance in microglia activation-mediated dopaminergic cell degeneration.
Wang X; Chen S; Ma G; Ye M; Lu G
Mech Ageing Dev; 2005 Dec; 126(12):1241-54. PubMed ID: 16112714
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial complex I inhibitor rotenone inhibits and redistributes vesicular monoamine transporter 2 via nitration in human dopaminergic SH-SY5Y cells.
Watabe M; Nakaki T
Mol Pharmacol; 2008 Oct; 74(4):933-40. PubMed ID: 18599602
[TBL] [Abstract][Full Text] [Related]
8. Modulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase after inhibiting monoamine oxidase-A.
Cho S; Duchemin AM; Neff NH; Hadjiconstantinou M
Eur J Pharmacol; 1996 Oct; 314(1-2):51-9. PubMed ID: 8957218
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of monoamine oxidase selectively in brain monoamine nerves using the bioprecursor (E)-beta-fluoromethylene-m-tyrosine (MDL 72394), a substrate for aromatic L-amino acid decarboxylase.
Palfreyman MG; McDonald IA; Fozard JR; Mely Y; Sleight AJ; Zreika M; Wagner J; Bey P; Lewis PJ
J Neurochem; 1985 Dec; 45(6):1850-60. PubMed ID: 3840523
[TBL] [Abstract][Full Text] [Related]
10. Role of aromatic L-amino acid decarboxylase for dopamine replacement by genetically modified fibroblasts in a rat model of Parkinson's disease.
Wachtel SR; Bencsics C; Kang UJ
J Neurochem; 1997 Nov; 69(5):2055-63. PubMed ID: 9349551
[TBL] [Abstract][Full Text] [Related]
11. Rotenone-induced PC12 cell toxicity is caused by oxidative stress resulting from altered dopamine metabolism.
Sai Y; Wu Q; Le W; Ye F; Li Y; Dong Z
Toxicol In Vitro; 2008 Sep; 22(6):1461-8. PubMed ID: 18579341
[TBL] [Abstract][Full Text] [Related]
12. Are striatal tyrosine hydroxylase interneurons dopaminergic?
Xenias HS; Ibáñez-Sandoval O; Koós T; Tepper JM
J Neurosci; 2015 Apr; 35(16):6584-99. PubMed ID: 25904808
[TBL] [Abstract][Full Text] [Related]
13. Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs.
Cho S; Neff NH; Hadjiconstantinou M
Eur J Pharmacol; 1997 Apr; 323(2-3):149-57. PubMed ID: 9128833
[TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein inhibits aromatic amino acid decarboxylase activity in dopaminergic cells.
Tehranian R; Montoya SE; Van Laar AD; Hastings TG; Perez RG
J Neurochem; 2006 Nov; 99(4):1188-96. PubMed ID: 16981894
[TBL] [Abstract][Full Text] [Related]
15. Effect on the dopaminergic metabolism induced by oral exposure to simazine during the prepubertal period in rats.
Li X; Yu J; Wu Y; Li B
Int J Mol Med; 2018 Jan; 41(1):421-429. PubMed ID: 29115391
[TBL] [Abstract][Full Text] [Related]
16. CGP 3466 protects dopaminergic neurons in lesion models of Parkinson's disease.
Waldmeier PC; Spooren WP; Hengerer B
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):526-37. PubMed ID: 11138845
[TBL] [Abstract][Full Text] [Related]
17. Induction of motor neuron apoptosis by free 3-nitro-L-tyrosine.
Peluffo H; Shacka JJ; Ricart K; Bisig CG; Martìnez-Palma L; Pritsch O; Kamaid A; Eiserich JP; Crow JP; Barbeito L; Estèvez AG
J Neurochem; 2004 May; 89(3):602-12. PubMed ID: 15086517
[TBL] [Abstract][Full Text] [Related]
18. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion.
Vaglini F; Pardini C; Cavalletti M; Maggio R; Corsini GU
Brain Res; 1996 Nov; 741(1-2):68-74. PubMed ID: 9001706
[TBL] [Abstract][Full Text] [Related]
19. Microtubule dysfunction by posttranslational nitrotyrosination of alpha-tubulin: a nitric oxide-dependent mechanism of cellular injury.
Eiserich JP; Estévez AG; Bamberg TV; Ye YZ; Chumley PH; Beckman JS; Freeman BA
Proc Natl Acad Sci U S A; 1999 May; 96(11):6365-70. PubMed ID: 10339593
[TBL] [Abstract][Full Text] [Related]
20. Differential loss of presynaptic dopaminergic markers in Parkinsonian monkeys.
Stephenson DT; Childs MA; Li Q; Carvajal-Gonzalez S; Opsahl A; Tengowski M; Meglasson MD; Merchant K; Emborg ME
Cell Transplant; 2007; 16(3):229-44. PubMed ID: 17503735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
